| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |